{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:13Z","timestamp":1792783453191,"version":"4.5.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Talent Introduction Project of Zhejiang Shuren University","award":["KXJ1723105"],"award-info":[{"award-number":["KXJ1723105"]}],"id":[{"id":"https:\/\/ror.org\/0331z5r71","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine","award":["SKLID2024KF07"],"award-info":[{"award-number":["SKLID2024KF07"]}],"id":[{"id":"https:\/\/ror.org\/05m1p5x56","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Shuren University Basic Scientific Research Special Funds","award":["KXJ1724104C and 2024XZ013"],"award-info":[{"award-number":["KXJ1724104C and 2024XZ013"]}],"id":[{"id":"https:\/\/ror.org\/0331z5r71","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05436-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:54:11Z","timestamp":1783097651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of HBV in reprogramming liver cancer stem cells and shaping their plasticity and therapeutic vulnerabilities"],"prefix":"10.1007","volume":"17","author":[{"given":"Hanlin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"5436_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-981-10-5765-6_2","volume":"1018","author":"Y Xie","year":"2017","unstructured":"Xie Y, Hepatitis B, Virus-Associated. Hepatocellular Carcinoma. Adv Exp Med Biol. 2017;1018:11\u201321.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"5436_CR2","first-page":"387","volume":"52","author":"VS Tharayil","year":"2006","unstructured":"Tharayil VS, Roberts LR. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2006;52(4):387\u2013406.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"5436_CR3","doi-asserted-by":"publisher","first-page":"205031212311666","DOI":"10.1177\/20503121231166642","volume":"11","author":"A Gedefie","year":"2023","unstructured":"Gedefie A, Seid A, Molla Fenta G, Tilahun M, Shibabaw A, Ali A. Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study. SAGE Open Med. 2023;11:20503121231166642.","journal-title":"SAGE Open Med"},{"issue":"10","key":"5436_CR4","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/vaccines11101530","volume":"11","author":"C Xu","year":"2023","unstructured":"Xu C, Wang Y, Cheng K, Yang X, Wang X, Guo S, et al. A Mathematical Model to Study the Potential Hepatitis B Virus Infections and Effects of Vaccination Strategies in China. Vaccines (Basel). 2023;11(10):1530.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"5436_CR5","doi-asserted-by":"publisher","first-page":"45557","DOI":"10.1038\/srep45557","volume":"7","author":"W Hur","year":"2017","unstructured":"Hur W, Ryu JY, Kim HU, Hong SW, Lee EB, Lee SY, et al. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133. Sci Rep. 2017;7(1):45557.","journal-title":"Sci Rep"},{"issue":"1","key":"5436_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","volume":"19","author":"TK Lee","year":"2022","unstructured":"Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19(1):26\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"5436_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2015.07.041","volume":"379","author":"Z Cheng","year":"2016","unstructured":"Cheng Z, Li X, Ding J. Characteristics of liver cancer stem cells and clinical correlations. Cancer Lett. 2016;379(2):230\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"5436_CR8","doi-asserted-by":"publisher","first-page":"7614971","DOI":"10.1155\/2016\/7614971","volume":"2016","author":"Y Xiang","year":"2016","unstructured":"Xiang Y, Yang T, Pang BY, Zhu Y, Liu YN. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int. 2016;2016(1):7614971.","journal-title":"Stem Cells Int"},{"issue":"1","key":"5436_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5115\/acb.22.161","volume":"56","author":"M Kim","year":"2023","unstructured":"Kim M, Jo KW, Kim H, Han ME, Oh SO. Genetic heterogeneity of liver cancer stem cells. Anat Cell Biol. 2023;56(1):94\u2013108.","journal-title":"Anat Cell Biol"},{"issue":"13","key":"5436_CR10","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.3748\/wjg.v22.i13.3547","volume":"22","author":"JH Sun","year":"2016","unstructured":"Sun JH, Luo Q, Liu LL, Song GB. Liver cancer stem cell markers: Progression and therapeutic implications. World J Gastroenterol. 2016;22(13):3547\u201357.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5436_CR11","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.clinre.2021.101664","volume":"45","author":"I Zar\u0119bska","year":"2021","unstructured":"Zar\u0119bska I, Gzil A, Dur\u015blewicz J, Jaworski D, Antosik P, Ahmadi N, et al. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clin Res Hepatol Gastroenterol. 2021;45(3):101664.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"5436_CR12","first-page":"2039","volume":"15","author":"L Qiu","year":"2018","unstructured":"Qiu L, Li H, Fu S, Chen X, Lu L. Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC. Oncol Lett. 2018;15(2):2039\u201348.","journal-title":"Oncol Lett"},{"issue":"2","key":"5436_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5144\/1658-3876.2011.60","volume":"4","author":"C Tomuleasa","year":"2011","unstructured":"Tomuleasa C, Soritau O, Fischer-Fodor E, Pop T, Susman S, Mosteanu O, et al. Arsenic trioxide plus cisplatin\/interferon alpha-2b\/doxorubicin\/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma. Hematol Oncol Stem Cell Ther. 2011;4(2):60\u20136.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4","key":"5436_CR14","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.celrep.2025.115457","volume":"44","author":"L Zhou","year":"2025","unstructured":"Zhou L, Liu CH, Lv D, Sample KM, Rojas A, Zhang Y, et al. Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease. Cell Rep. 2025;44(4):115457.","journal-title":"Cell Rep"},{"issue":"4","key":"5436_CR15","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hep.22743","volume":"49","author":"W Ding","year":"2009","unstructured":"Ding W, Mouzaki M, You H, Laird JC, Mato J, Lu SC, et al. CD133\u2009+\u2009liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology. 2009;49(4):1277\u201386.","journal-title":"Hepatology"},{"issue":"12","key":"5436_CR16","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1097\/CM9.0000000000003171","volume":"137","author":"Y Xu","year":"2024","unstructured":"Xu Y, Xia C, Li H, Cao M, Yang F, Li Q, et al. Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study. Chin Med J (Engl). 2024;137(12):1414\u201320.","journal-title":"Chin Med J (Engl)"},{"issue":"1 Suppl","key":"5436_CR17","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):S84\u2013101.","journal-title":"J Hepatol"},{"issue":"4","key":"5436_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652\u20137.","journal-title":"J Hepatol"},{"key":"5436_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-030-23629-8_10","volume":"1167","author":"SR Singh","year":"2019","unstructured":"Singh SR, Aggarwal P, Hou SX. Cancer Stem Cells and Stem Cell Tumors in Drosophila. Adv Exp Med Biol. 2019;1167:175\u201390.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"5436_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-021-00030-7","volume":"2","author":"N Mukaida","year":"2021","unstructured":"Mukaida N, Tanabe Y, Baba T. Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia. Molecular Biomedicine. 2021;2(1):7.","journal-title":"Molecular Biomedicine"},{"issue":"6","key":"5436_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Kim","year":"2005","unstructured":"Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121(6):823\u201335.","journal-title":"Cell"},{"issue":"3","key":"5436_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1(3):313\u201323.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"5436_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030\u20137.","journal-title":"Cancer Res"},{"issue":"7123","key":"5436_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106\u201310.","journal-title":"Nature"},{"key":"5436_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdev.2022.203776","volume":"170","author":"F Chowdhury","year":"2022","unstructured":"Chowdhury F, Huang B, Wang N. Forces in stem cells and cancer stem cells. Cells & Development. 2022;170:203776.","journal-title":"Cells & Development"},{"issue":"7","key":"5436_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biom12070941","volume":"12","author":"HY Chen","year":"2022","unstructured":"Chen HY, Cheng AJ. Potential to eradicate cancer stemness by targeting cell surface GRP78. Biomolecules. 2022;12(7):941.","journal-title":"Biomolecules"},{"issue":"15","key":"5436_CR27","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-10-2538","volume":"17","author":"M Maugeri-Sacca","year":"2011","unstructured":"Maugeri-Sacca M, Vigneri P, De Maria R. Cancer stem cells and chemosensitivity. Clin Cancer Res. 2011;17(15):4942\u20137.","journal-title":"Clin Cancer Res"},{"issue":"7120","key":"5436_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"4","key":"5436_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5(4):275\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5436_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"10","key":"5436_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"5436_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15(6):501\u201313.","journal-title":"Cancer Cell"},{"issue":"5","key":"5436_CR33","first-page":"650","volume":"51","author":"C Chen","year":"2020","unstructured":"Chen C, Xu ZH, Wang L. [The Effect of Morusin on Stemness Phenotype of Laryngeal Cancer Stem Cell]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(5):650\u20137.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"12","key":"5436_CR34","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.3934\/mbe.2022650","volume":"19","author":"J Yang","year":"2022","unstructured":"Yang J, Xu H, Li C, Li Z, Hu Z. An explorative study for leveraging transcriptomic data of embryonic stem cells in mining cancer stemness genes, regulators, and networks. Math Biosci Eng. 2022;19(12):13949\u201366.","journal-title":"Math Biosci Eng"},{"issue":"1","key":"5436_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","volume":"154","author":"CL Chaffer","year":"2013","unstructured":"Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 2013;154(1):61\u201374.","journal-title":"Cell"},{"key":"5436_CR36","doi-asserted-by":"publisher","first-page":"691410","DOI":"10.3389\/fcell.2021.691410","volume":"9","author":"D Lv","year":"2021","unstructured":"Lv D, Chen L, Du L, Zhou L, Tang H. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021;9:691410.","journal-title":"Front Cell Dev Biol"},{"key":"5436_CR37","doi-asserted-by":"crossref","unstructured":"Guo W, Lasky JL 3rd, Wu H. Cancer stem cells. Pediatr Res. 2006;59(4 Pt 2):R59\u201364.","DOI":"10.1203\/01.pdr.0000203592.04530.06"},{"issue":"4","key":"5436_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbrc.2006.10.128","volume":"351","author":"A Suetsugu","year":"2006","unstructured":"Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133\u2009+\u2009hepatocellular carcinoma cells as cancer stem\/progenitor cells. Biochem Biophys Res Commun. 2006;351(4):820\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"5436_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","volume":"136","author":"T Yamashita","year":"2009","unstructured":"Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features. Gastroenterology. 2009;136(3):1012\u201324.","journal-title":"Gastroenterology"},{"issue":"2","key":"5436_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2008.01.013","volume":"13","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90\u2009+\u2009cancer stem cells in human liver cancer. Cancer Cell. 2008;13(2):153\u201366.","journal-title":"Cancer Cell"},{"key":"5436_CR41","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2019.13","author":"J-L Zhang","year":"2019","unstructured":"Zhang J-L, Gong L, Yan Q, Zhou N-N, Lee V-F, Guan X. Advances in surface markers of liver cancer stem cell. Hepatoma Res. 2019. https:\/\/doi.org\/10.20517\/2394-5079.2019.13.","journal-title":"Hepatoma Res"},{"issue":"1","key":"5436_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2011.06.005","volume":"9","author":"TKW Lee","year":"2011","unstructured":"Lee TKW, Castilho A, Cheung VCH, Tang KH, Ma S, Ng IOL. CD24\u2009+\u2009liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell stem cell. 2011;9(1):50\u201363.","journal-title":"Cell stem cell"},{"key":"5436_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1070961","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Han J, Yang Y, Chen Y. PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol. 2022;13:1070961.","journal-title":"Front Immunol"},{"issue":"3","key":"5436_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jhep.2012.04.024","volume":"57","author":"W Yang","year":"2012","unstructured":"Yang W, Wang C, Lin Y, Liu Q, Yu L-x, Tang L, et al. OV6\u2009+\u2009tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma. Journal of hepatology. 2012;57(3):613\u201320.","journal-title":"Journal of hepatology"},{"issue":"9","key":"5436_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"S Zhou","year":"2001","unstructured":"Zhou S, Schuetz JD, Bunting KD, Colapietro A-M, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature medicine. 2001;7(9):1028\u201334.","journal-title":"Nature medicine"},{"issue":"12","key":"5436_CR46","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/carcin\/bgn223","volume":"29","author":"C Hu","year":"2008","unstructured":"Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, et al. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Carcinogenesis. 2008;29(12):2289\u201397.","journal-title":"Carcinogenesis"},{"issue":"7","key":"5436_CR47","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","volume":"132","author":"S Ma","year":"2007","unstructured":"Ma S, Chan KW, Hu L, Lee TKW, Wo JYH, Ng IOL, et al. Identification and characterization of tumorigenic liver cancer stem\/progenitor cells. Gastroenterology. 2007;132(7):2542\u201356.","journal-title":"Gastroenterology"},{"key":"5436_CR48","doi-asserted-by":"publisher","first-page":"598855","DOI":"10.3389\/fgene.2021.598855","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Shui L, Liu Y, Zheng M. C-Kit, a double-edged sword in liver regeneration and diseases. Front Genet. 2021;12:598855.","journal-title":"Front Genet"},{"issue":"31","key":"5436_CR49","doi-asserted-by":"publisher","first-page":"e4224","DOI":"10.1097\/MD.0000000000004224","volume":"95","author":"Z Li","year":"2016","unstructured":"Li Z, Zhao X, Jiang P, Xiao S, Wu G, Chen K, et al. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case\u2013control study. Medicine. 2016;95(31):e4224.","journal-title":"Medicine"},{"issue":"2","key":"5436_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ijmm.2012.1208","volume":"31","author":"X Lan","year":"2013","unstructured":"Lan X, Wu YZ, Wang Y, Wu FR, Zang CB, Tang C, et al. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells. Int J Mol Med. 2013;31(2):315\u201324.","journal-title":"Int J Mol Med"},{"issue":"1","key":"5436_CR51","first-page":"15","volume":"13","author":"X Jin","year":"2025","unstructured":"Jin X, Dong H, Wang J, Ou G, Lai X, Tian X, et al. HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells. J Clin Transl Hepatol. 2025;13(1):15\u201324.","journal-title":"J Clin Transl Hepatol"},{"issue":"11","key":"5436_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111646","volume":"11","author":"C Lee","year":"2019","unstructured":"Lee C, Cheung ST. STAT3: an emerging therapeutic target for hepatocellular carcinoma. Cancers (Basel). 2019;11(11):1646.","journal-title":"Cancers (Basel)"},{"key":"5436_CR53","doi-asserted-by":"publisher","first-page":"217541","DOI":"10.1016\/j.canlet.2025.217541","volume":"614","author":"Y Zhai","year":"2025","unstructured":"Zhai Y, Li G, Pan C, Yu M, Hu H, Wang D, et al. The development and potent antitumor efficacy of CD44\/CD133 dual-targeting IL7R\u03b1-armored CAR-T cells against glioblastoma. Cancer Lett. 2025;614:217541.","journal-title":"Cancer Lett"},{"issue":"1","key":"5436_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03016-0","volume":"21","author":"C Yang","year":"2023","unstructured":"Yang C, You J, Pan Q, Tang Y, Cai L, Huang Y, et al. Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma. BMC medicine. 2023;21(1):327.","journal-title":"BMC medicine"},{"issue":"5","key":"5436_CR55","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2016.05.022","volume":"65","author":"SKK Mani","year":"2016","unstructured":"Mani SKK, Zhang H, Diab A, Pascuzzi PE, Lefran\u00e7ois L, Fares N, et al. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes. Journal of hepatology. 2016;65(5):888\u201398.","journal-title":"Journal of hepatology"},{"issue":"1","key":"5436_CR56","first-page":"1","volume":"16","author":"P Liu","year":"2025","unstructured":"Liu P, Zhang Q, Liu F. Biological roles and clinical applications of EpCAM in HCC. Discover Oncology. 2025;16(1):1\u201311.","journal-title":"Discover Oncology"},{"issue":"11","key":"5436_CR57","first-page":"854","volume":"23","author":"L-M Yu","year":"2015","unstructured":"Yu L-M, Luo N, Li Q-L, Chen S, He S. EPCAM-positive normal hepatic progenitor cells transformation into liver stem cells and HBx-mediated effects on stability in adult mouse. Zhonghua gan Zang Bing za zhi= Zhonghua Ganzangbing Zazhi=. Chin J Hepatol. 2015;23(11):854\u20139.","journal-title":"Chin J Hepatol"},{"issue":"2","key":"5436_CR58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/hep4.1462","volume":"4","author":"K Ishiguro","year":"2020","unstructured":"Ishiguro K, Yan IK, Lewis-Tuffin L, Patel T. Targeting Liver Cancer Stem Cells Using Engineered Biological Nanoparticles for the Treatment of Hepatocellular Cancer. Hepatol Commun. 2020;4(2):298\u2013313.","journal-title":"Hepatol Commun"},{"issue":"48","key":"5436_CR59","doi-asserted-by":"publisher","first-page":"eadg9721","DOI":"10.1126\/sciadv.adg9721","volume":"9","author":"D Li","year":"2023","unstructured":"Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, et al. EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors. Sci Adv. 2023;9(48):eadg9721.","journal-title":"Sci Adv"},{"issue":"1","key":"5436_CR60","doi-asserted-by":"publisher","first-page":"31530","DOI":"10.1038\/s41598-024-83145-5","volume":"14","author":"A Lin","year":"2024","unstructured":"Lin A, Wang M, Wang Z, Lin J, Lin Z, Lin S, et al. Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma. Sci Rep. 2024;14(1):31530.","journal-title":"Sci Rep"},{"issue":"4","key":"5436_CR61","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.ymthe.2021.01.006","volume":"29","author":"K Du","year":"2021","unstructured":"Du K, Li Y, Liu J, Chen W, Wei Z, Luo Y, et al. A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC. Mol Ther. 2021;29(4):1572\u201384.","journal-title":"Mol Ther"},{"issue":"1","key":"5436_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hep.27070","volume":"60","author":"TK Lee","year":"2014","unstructured":"Lee TK, Cheung VC, Lu P, Lau EY, Ma S, Tang KH, et al. Blockade of CD47-mediated cathepsin S\/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology. 2014;60(1):179\u201391.","journal-title":"Hepatology"},{"issue":"5","key":"5436_CR63","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/liv.12963","volume":"36","author":"J Lo","year":"2016","unstructured":"Lo J, Lau EY, So FT, Lu P, Chan VS, Cheung VC, et al. Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma. Liver Int. 2016;36(5):737\u201345.","journal-title":"Liver Int"},{"key":"5436_CR64","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.iotech.2022.100070","volume":"13","author":"R Maute","year":"2022","unstructured":"Maute R, Xu J, Weissman IL. CD47-SIRP\u03b1-targeted therapeutics: status and prospects. Immunooncol Technol. 2022;13:100070.","journal-title":"Immunooncol Technol"},{"issue":"14","key":"5436_CR65","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.3390\/cancers14143366","volume":"14","author":"LM Behrens","year":"2022","unstructured":"Behrens LM, van den Berg TK, van Egmond M. Targeting the CD47-SIRPalpha Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils. Cancers (Basel). 2022;14(14):3366.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"5436_CR66","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/jhep.2001.1270","volume":"33","author":"E Lara-Pezzi","year":"2001","unstructured":"Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yanez-Mo M, Carretero M, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology. 2001;33(5):1270\u201381.","journal-title":"Hepatology"},{"issue":"12","key":"5436_CR67","doi-asserted-by":"publisher","first-page":"689","DOI":"10.21037\/atm-22-2482","volume":"10","author":"P Xie","year":"2022","unstructured":"Xie P, Yan J, Wu M, Li H, Chen Z, Yu M, et al. CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT\/ERK signaling CXCR4 axis. Annals Translational Med. 2022;10(12):689.","journal-title":"Annals Translational Med"},{"issue":"5","key":"5436_CR68","first-page":"1276","volume":"21","author":"M Haramaki","year":"1995","unstructured":"Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M. Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology. 1995;21(5):1276\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"5436_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2010.10.130","volume":"403","author":"JC Henry","year":"2010","unstructured":"Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR, et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2010;403(1):120\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5436_CR70","doi-asserted-by":"publisher","first-page":"6096","DOI":"10.3390\/ijms15046096","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Wang F, Zhao H, Zhang X, Chen H, Zhang K. Human adipose-derived mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vitro. Int J Mol Sci. 2014;15(4):6096\u2013110.","journal-title":"Int J Mol Sci"},{"issue":"28","key":"5436_CR71","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","volume":"17","author":"B-J Wang","year":"2011","unstructured":"Wang B-J, Bao J-J, Wang J-Z, Wang Y, Jiang M, Xing M-Y, et al. Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World J gastroenterology: WJG. 2011;17(28):3322.","journal-title":"World J gastroenterology: WJG"},{"key":"5436_CR72","doi-asserted-by":"publisher","first-page":"1323581","DOI":"10.3389\/fimmu.2023.1323581","volume":"14","author":"L Hao","year":"2023","unstructured":"Hao L, Li S, Deng J, Li N, Yu F, Jiang Z, et al. The current status and future of PD-L1 in liver cancer. Front Immunol. 2023;14:1323581.","journal-title":"Front Immunol"},{"issue":"1","key":"5436_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12967-024-05069-y","volume":"22","author":"Y Jia","year":"2024","unstructured":"Jia Y, Zhao J, Wang C, Meng J, Zhao L, Yang H, et al. HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma. J Transl Med. 2024;22(1):272.","journal-title":"J Transl Med"},{"issue":"2","key":"5436_CR74","doi-asserted-by":"publisher","first-page":"e001377","DOI":"10.1136\/jitc-2020-001377","volume":"8","author":"Z Chen","year":"2020","unstructured":"Chen Z, Chen Y, Peng L, Wang X, Tang N. 2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1. J Immunother Cancer. 2020;8(2):e001377.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5436_CR75","doi-asserted-by":"publisher","first-page":"101153","DOI":"10.1016\/j.aohep.2023.101153","volume":"29","author":"CH Sukowati","year":"2024","unstructured":"Sukowati CH, El-Khobar K, Jasirwan COM, Kurniawan J, Gani RA. Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? Ann Hepatol. 2024;29(1):101153.","journal-title":"Ann Hepatol"},{"issue":"1","key":"5436_CR76","doi-asserted-by":"publisher","first-page":"e2560","DOI":"10.1038\/cddis.2016.493","volume":"8","author":"C Wang","year":"2018","unstructured":"Wang C, Wang M-d, Cheng P, Huang H, Dong W, Zhang W-w, et al. Hepatitis B virus X protein promotes the stem-like properties of OV6\u2009+\u2009cancer cells in hepatocellular carcinoma. Cell Death Dis. 2018;8(1):e2560\u2013e.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5436_CR77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4252\/wjsc.v15.i4.209","volume":"15","author":"S-H Xuan","year":"2023","unstructured":"Xuan S-H, Hua M-L, Xiang Z, He X-L, Huang L, Jiang C, et al. Roles of cancer stem cells in gastrointestinal cancers. World J Stem Cells. 2023;15(4):209.","journal-title":"World J Stem Cells"},{"issue":"2","key":"5436_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4254\/wjh.v16.i2.164","volume":"16","author":"XQ Zhou","year":"2024","unstructured":"Zhou XQ, Li YP, Dang SS. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World J Hepatol. 2024;16(2):164\u201376.","journal-title":"World J Hepatol"},{"key":"5436_CR79","doi-asserted-by":"publisher","first-page":"101509","DOI":"10.1016\/j.tranon.2022.101509","volume":"25","author":"MD Wang","year":"2022","unstructured":"Wang MD, Xiang H, Zhang L, Wang C. Integration of OV6 expression and CD68(+) tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma. Transl Oncol. 2022;25:101509.","journal-title":"Transl Oncol"},{"key":"5436_CR80","first-page":"5108653","volume":"2017","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Lin M, Jiang X, Ye J, Guo T, Shi Y, et al. The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy. Anal Cell Pathol (Amst). 2017;2017:5108653.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"9","key":"5436_CR81","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1172\/JCI42550","volume":"120","author":"N Haraguchi","year":"2010","unstructured":"Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, et al. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Investig. 2010;120(9):3326\u201339.","journal-title":"J Clin Investig"},{"key":"5436_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0572-9","volume":"16","author":"K Nio","year":"2017","unstructured":"Nio K, Yamashita T, Kaneko S. The evolving concept of liver cancer stem cells. Mol Cancer. 2017;16:1\u201312.","journal-title":"Mol Cancer"},{"key":"5436_CR83","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3389\/fphar.2018.01042","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Fang C, Qu M, Wu H, Wang X, Zhang H, et al. CD13 inhibition enhances cytotoxic effect of chemotherapy agents. Front Pharmacol. 2018;9:1042.","journal-title":"Front Pharmacol"},{"issue":"42","key":"5436_CR84","doi-asserted-by":"publisher","first-page":"72652","DOI":"10.18632\/oncotarget.20194","volume":"8","author":"Q Guo","year":"2017","unstructured":"Guo Q, Sui ZG, Xu W, Quan XH, Sun JL, Li X, et al. Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells. Oncotarget. 2017;8(42):72652\u201365.","journal-title":"Oncotarget"},{"key":"5436_CR85","doi-asserted-by":"publisher","first-page":"105343","DOI":"10.1016\/j.bioorg.2021.105343","volume":"116","author":"K Yue","year":"2021","unstructured":"Yue K, Hou X, Jia G, Zhang L, Zhang J, Tan L, et al. Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy. Bioorg Chem. 2021;116:105343.","journal-title":"Bioorg Chem"},{"key":"5436_CR86","doi-asserted-by":"publisher","first-page":"156271","DOI":"10.1016\/j.cyto.2023.156271","volume":"169","author":"M Zhou","year":"2023","unstructured":"Zhou M, Na R, Lai S, Guo Y, Shi J, Nie J, et al. The present roles and future perspectives of Interleukin-6 in biliary tract cancer. Cytokine. 2023;169:156271.","journal-title":"Cytokine"},{"issue":"1","key":"5436_CR87","doi-asserted-by":"publisher","first-page":"e000930","DOI":"10.1136\/jitc-2020-000930","volume":"8","author":"FI Arnaldez","year":"2020","unstructured":"Arnaldez FI, O\u2019Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, et al. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer. 2020;8(1):e000930.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"5436_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci. 2012;122(4):143\u201359.","journal-title":"Clin Sci"},{"key":"5436_CR89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4939-7568-6_11","volume":"1725","author":"C Garbers","year":"2018","unstructured":"Garbers C, Rose-John S. Dissecting Interleukin-6 Classic- and Trans-Signaling in Inflammation and Cancer. Methods Mol Biol. 2018;1725:127\u201340.","journal-title":"Methods Mol Biol"},{"issue":"19","key":"5436_CR90","doi-asserted-by":"publisher","first-page":"10763","DOI":"10.1128\/JVI.01197-13","volume":"87","author":"JM Reitsma","year":"2013","unstructured":"Reitsma JM, Sato H, Nevels M, Terhune SS, Paulus C. Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J Virol. 2013;87(19):10763\u201376.","journal-title":"J Virol"},{"issue":"1","key":"5436_CR91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4049\/jimmunol.178.1.345","volume":"178","author":"Z Ni","year":"2007","unstructured":"Ni Z, Bremner R. Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes. J Immunol. 2007;178(1):345\u201351.","journal-title":"J Immunol"},{"issue":"4","key":"5436_CR92","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.molcel.2012.06.014","volume":"47","author":"H Korkaya","year":"2012","unstructured":"Korkaya H, Kim GI, Davis A, Malik F, Henry NL, Ithimakin S, et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2\u2009+\u2009breast cancer by expanding the cancer stem cell population. Mol Cell. 2012;47(4):570\u201384.","journal-title":"Mol Cell"},{"key":"5436_CR93","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073351630241128182125","author":"Y Ding","year":"2024","unstructured":"Ding Y, Hong Y, Zou Y, Wang X, Liu X, Jiang X, et al. Bushen Zhuyun Decoction Enhances Endometrial Receptivity via the IL-6\/STAT3 Signaling Pathway in Rats. Comb Chem High Throughput Screen. 2024. https:\/\/doi.org\/10.2174\/0113862073351630241128182125.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"12","key":"5436_CR94","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/jpm13121675","volume":"13","author":"K Dimitriadis","year":"2023","unstructured":"Dimitriadis K, Katelani S, Pappa M, Fragkoulis GE, Androutsakos T. The Role of Interleukins in HBV Infection: A Narrative Review. J Pers Med. 2023;13(12):1675.","journal-title":"J Pers Med"},{"issue":"1","key":"5436_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000455954","volume":"41","author":"Z Chen","year":"2017","unstructured":"Chen Z, Li YX, Fu HJ, Ren YL, Zou L, Shen SZ, et al. Hepatitis B Virus Core Antigen Stimulates IL-6 Expression via p38, ERK and NF-kappaB Pathways in Hepatocytes. Cell Physiol Biochem. 2017;41(1):91\u2013100.","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"5436_CR96","doi-asserted-by":"publisher","first-page":"e0159089","DOI":"10.1371\/journal.pone.0159089","volume":"11","author":"YX Li","year":"2016","unstructured":"Li YX, Ren YL, Fu HJ, Zou L, Yang Y, Chen Z. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK\/NF-kappaB Pathways in an ER Stress-Dependent Manner. PLoS ONE. 2016;11(7):e0159089.","journal-title":"PLoS ONE"},{"issue":"14","key":"5436_CR97","doi-asserted-by":"publisher","first-page":"23507","DOI":"10.18632\/oncotarget.15183","volume":"8","author":"RHH Ching","year":"2017","unstructured":"Ching RHH, Sze KMF, Lau EYT, Chiu Y-T, Lee JMF, Ng IOL, et al. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3\/Nanog signaling pathway. Oncotarget. 2017;8(14):23507.","journal-title":"Oncotarget"},{"issue":"7","key":"5436_CR98","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrm2717","volume":"10","author":"S Angers","year":"2009","unstructured":"Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009;10(7):468\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"5436_CR99","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1042\/BST20200026","volume":"48","author":"P Astudillo","year":"2020","unstructured":"Astudillo P. Extracellular matrix stiffness and Wnt\/\u03b2-catenin signaling in physiology and disease. Biochem Soc Trans. 2020;48(3):1187\u201398.","journal-title":"Biochem Soc Trans"},{"key":"5436_CR100","doi-asserted-by":"publisher","unstructured":"Lybrand DB, Naiman M, Laumann JM, Boardman M, Petshow S, Hansen K, et al. Destruction complex dynamics: Wnt\/\u03b2-catenin signaling alters Axin-GSK3\u03b2 interactions in in vivo. Development. 2019. https:\/\/doi.org\/10.1242\/dev.164145.","DOI":"10.1242\/dev.164145"},{"key":"5436_CR101","doi-asserted-by":"crossref","unstructured":"Torresi J, Tran BM, Christiansen D, Earnest-Silveira L, Schwab RHM, Vincan E. HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. BMC Cancer. 2019;19:1\u201314.","DOI":"10.1186\/s12885-019-5916-6"},{"key":"5436_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11010-013-1769-5","volume":"383","author":"L Shen","year":"2013","unstructured":"Shen L, Zhang X, Hu D, Feng T, Li H, Lu Y, et al. Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt\/\u03b2-catenin pathway. Mol Cell Biochem. 2013;383:213\u201322.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"5436_CR103","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","volume":"71","author":"A Arzumanyan","year":"2011","unstructured":"Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 2011;71(10):3701\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"5436_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061435","volume":"12","author":"BM Tran","year":"2020","unstructured":"Tran BM, Flanagan DJ, Ebert G, Warner N, Tran H, Fifis T, et al. The hepatitis B virus pre-core protein p22 activates Wnt signaling. Cancers. 2020;12(6):1435.","journal-title":"Cancers"},{"issue":"5","key":"5436_CR105","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jb\/mvab088","volume":"170","author":"T Sun","year":"2021","unstructured":"Sun T, Zhang J. ETV4 mediates the Wnt\/\u03b2-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. J Biochem. 2021;170(5):663\u201373.","journal-title":"J Biochem"},{"key":"5436_CR106","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4939-8910-2_18","volume":"1893","author":"L Ni","year":"2019","unstructured":"Ni L, Luo X. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway. Methods Mol Biol. 2019;1893:239\u201356.","journal-title":"Methods Mol Biol"},{"key":"5436_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03033","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Lu W, Zhang Y, Zou F, Jin Z, Zhao T. The Hippo pathway and viral infections. Front Microbiol. 2020;10:3033.","journal-title":"Front Microbiol"},{"issue":"6","key":"5436_CR108","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1074\/mcp.M116.065490","volume":"16","author":"AL Couzens","year":"2017","unstructured":"Couzens AL, Xiong S, Knight JD, Mao DY, Guettler S, Picaud S, et al. MOB1 mediated phospho-recognition in the core mammalian Hippo pathway. Mol Cell Proteom. 2017;16(6):1098\u2013110.","journal-title":"Mol Cell Proteom"},{"key":"5436_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151427","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Yuan Y, Peng Y, Xia X, Chen Q, Yu F-X, et al. Distinct Effects of Hippo-YAP\/TAZ and YAP\/TAZ-TEAD in Epithelial Maintenance and Repair. Biochem Biophys Res Commun. 2025. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151427.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5436_CR110","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1158\/0008-5472.CAN-24-0456","volume":"85","author":"RE Turnham","year":"2025","unstructured":"Turnham RE, Pitea A, Jang GM, Xu Z, Lim HC, Choi AL, et al. HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma. Cancer Res. 2025;85(4):660\u201374.","journal-title":"Cancer Res"},{"issue":"4","key":"5436_CR111","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/v15040857","volume":"15","author":"K Padarath","year":"2023","unstructured":"Padarath K, Deroubaix A, Kramvis A. The complex role of HBeAg and its precursors in the pathway to hepatocellular carcinoma. Viruses. 2023;15(4):857.","journal-title":"Viruses"},{"issue":"1","key":"5436_CR112","doi-asserted-by":"publisher","first-page":"e28436","DOI":"10.1002\/jmv.28436","volume":"95","author":"A Kar","year":"2023","unstructured":"Kar A, Samanta A, Mukherjee S, Barik S, Biswas A. The HBV web: An insight into molecular interactomes between the hepatitis B virus and its host en route to hepatocellular carcinoma. J Med Virol. 2023;95(1):e28436.","journal-title":"J Med Virol"},{"issue":"7","key":"5436_CR113","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/cancers11071028","volume":"11","author":"D Rodriguez","year":"2019","unstructured":"Rodriguez D, Ramkairsingh M, Lin X, Kapoor A, Major P, Tang D. The central contributions of breast cancer stem cells in developing resistance to endocrine therapy in estrogen receptor (ER)-positive breast cancer. Cancers. 2019;11(7):1028.","journal-title":"Cancers"},{"key":"5436_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10565-016-9364-7","volume":"33","author":"X Luo","year":"2017","unstructured":"Luo X, Xu L, Li Y, Tan H. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD. Cell Biol Toxicol. 2017;33:169\u201381.","journal-title":"Cell Biol Toxicol"},{"key":"5436_CR115","doi-asserted-by":"publisher","first-page":"115474","DOI":"10.1016\/j.bone.2020.115474","volume":"138","author":"J Yu","year":"2020","unstructured":"Yu J, Canalis E. Notch and the regulation of osteoclast differentiation and function. Bone. 2020;138:115474.","journal-title":"Bone"},{"issue":"6","key":"5436_CR116","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00776-005-0943-3","volume":"10","author":"Y Yabe","year":"2005","unstructured":"Yabe Y, Matsumoto T, Tsurumoto T, Shindo H. Immunohistological localization of Notch receptors and their ligands Delta and Jagged in synovial tissues of rheumatoid arthritis. J Orthop Sci. 2005;10(6):589\u201394.","journal-title":"J Orthop Sci"},{"issue":"6","key":"5436_CR117","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1073\/pnas.052017699","volume":"99","author":"Y Taniguchi","year":"2002","unstructured":"Taniguchi Y, Karlstr\u00f6m H, Lundkvist J, Mizutani T, Otaka A, Vestling M, et al. Notch receptor cleavage depends on but is not directly executed by presenilins. Proc Natl Acad Sci. 2002;99(6):4014\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"5436_CR118","doi-asserted-by":"publisher","first-page":"106557","DOI":"10.1016\/j.micpath.2024.106557","volume":"188","author":"Z Yin","year":"2024","unstructured":"Yin Z, Zhu Y, Shi J, Zhang F. The role of the Notch signaling pathway in bacterial infectious diseases. Microb Pathog. 2024;188:106557.","journal-title":"Microb Pathog"},{"key":"5436_CR119","doi-asserted-by":"publisher","first-page":"199273","DOI":"10.1016\/j.virusres.2023.199273","volume":"339","author":"X Wen","year":"2024","unstructured":"Wen X, Li D, Chen P, Tan M, Zhang H, Liu Y, et al. Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway. Virus Res. 2024;339:199273.","journal-title":"Virus Res"},{"issue":"3","key":"5436_CR120","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jhep.2020.09.032","volume":"74","author":"C Zhu","year":"2021","unstructured":"Zhu C, Ho Y-J, Salomao MA, Dapito DH, Bartolome A, Schwabe RF, et al. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. J Hepatol. 2021;74(3):613\u201326.","journal-title":"J Hepatol"},{"issue":"3","key":"5436_CR121","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/cells10030521","volume":"10","author":"C Giovannini","year":"2021","unstructured":"Giovannini C, Fornari F, Piscaglia F, Gramantieri L. Notch signaling regulation in HCC: from hepatitis virus to non-coding RNAs. Cells. 2021;10(3):521.","journal-title":"Cells"},{"issue":"7","key":"5436_CR122","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.4103\/jcrt.JCRT_482_17","volume":"15","author":"H Cai","year":"2019","unstructured":"Cai H, Lu W, Zhang Y, Liu H, Wang Z, Shen Y. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells. J Cancer Res Ther. 2019;15(7):1547\u201352.","journal-title":"J Cancer Res Ther"},{"key":"5436_CR123","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1074\/jbc.RA120.015335","volume":"296","author":"Y Deng","year":"2021","unstructured":"Deng Y, Li M, Zhuo M, Guo P, Chen Q, Mo P, et al. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression. J Biol Chem. 2021;296:100121.","journal-title":"J Biol Chem"},{"issue":"4","key":"5436_CR124","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3892\/or.2012.1620","volume":"27","author":"F Wang","year":"2012","unstructured":"Wang F, Zhou H, Yang Y, Xia X, Sun Q, Luo J, et al. Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep. 2012;27(4):1170\u20136.","journal-title":"Oncol Rep"},{"key":"5436_CR125","doi-asserted-by":"crossref","unstructured":"Wang PP, Xie DY, Liang XJ, Peng L, Zhang GL, Ye YN,\u00a0et al. HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4\/NF-kB pathway.\u00a0Public Library of Science San Francisco.\u00a02012.","DOI":"10.1371\/journal.pone.0043408"},{"issue":"4","key":"5436_CR126","doi-asserted-by":"publisher","first-page":"e03068","DOI":"10.1128\/mbio.03068-23","volume":"15","author":"J Tang","year":"2024","unstructured":"Tang J, Zhang J, Zhang G, Peng W, Ling N, Zhou Y, et al. Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation. Mbio. 2024;15(4):e03068\u201323.","journal-title":"Mbio"},{"issue":"1","key":"5436_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00618-y","volume":"19","author":"X Li","year":"2024","unstructured":"Li X, Kong D, Hu W, Zheng K, You H, Tang R, et al. Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein. Infect Agent Cancer. 2024;19(1):56.","journal-title":"Infect Agent Cancer"},{"key":"5436_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.691410","author":"D Lv","year":"2021","unstructured":"Lv D, Chen L, Du L, Zhou L, Tang H. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.691410.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"5436_CR129","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/bdrc.10017","volume":"69","author":"LM Eisenberg","year":"2003","unstructured":"Eisenberg LM, Eisenberg CA. Stem cell plasticity, cell fusion, and transdifferentiation. Birth Defects Res C Embryo Today. 2003;69(3):209\u201318.","journal-title":"Birth Defects Res C Embryo Today"},{"key":"5436_CR130","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ceb.2016.07.005","volume":"43","author":"PR Tata","year":"2016","unstructured":"Tata PR, Rajagopal J. Cellular plasticity: 1712 to the present day. Curr Opin Cell Biol. 2016;43:46\u201354.","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"5436_CR131","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/cr.2010.59","volume":"20","author":"J Taylor","year":"2010","unstructured":"Taylor J, Wilmut I, Sullivan G. What are the limits to cell plasticity? Cell Res. 2010;20(5):502\u20133.","journal-title":"Cell Res"},{"issue":"1","key":"5436_CR132","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1099\/jgv.0.000324","volume":"97","author":"S Shin Kim","year":"2016","unstructured":"Shin Kim S, Yeom S, Kwak J, Ahn H-J, Lib Jang K. Hepatitis B virus X protein induces epithelial\u2013mesenchymal transition by repressing E-cadherin expression via upregulation of E12\/E47. J Gen Virol. 2016;97(1):134\u201343.","journal-title":"J Gen Virol"},{"issue":"3","key":"5436_CR133","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/carcin\/bgz109","volume":"41","author":"J Ahodantin","year":"2020","unstructured":"Ahodantin J, Lekbaby B, Bou Nader M, Soussan P, Kremsdorf D. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells. Carcinogenesis. 2020;41(3):358\u201367.","journal-title":"Carcinogenesis"},{"key":"5436_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101670","volume":"73","author":"A Tiwari","year":"2021","unstructured":"Tiwari A, Ashary N, Singh N, Sharma S, Modi D. Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli. Tissue Cell. 2021;73:101670.","journal-title":"Tissue Cell"},{"issue":"5","key":"5436_CR135","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5483\/BMBRep.2022.55.5.157","volume":"55","author":"I Kang","year":"2022","unstructured":"Kang I, Kim JA, Kim J, Lee JH, Kim M-j, Ahn JK. Hepatitis B virus X protein promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating SOCS1. BMB Rep. 2022;55(5):220.","journal-title":"BMB Rep"},{"issue":"5","key":"5436_CR136","first-page":"5709","volume":"16","author":"Y Zha","year":"2018","unstructured":"Zha Y, Yao Q, Liu J-S, Wang Y-Y, Sun W-M. Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2. Oncol Lett. 2018;16(5):5709\u201314.","journal-title":"Oncol Lett"},{"issue":"2","key":"5436_CR137","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3892\/mmr.2015.4644","volume":"13","author":"YH Wu","year":"2016","unstructured":"Wu YH, Ai X, Liu FY, Liang HF, Zhang BX, Chen XP. C-Jun N-terminal kinase inhibitor favors transforming growth factor\u2011\u03b2 to antagonize hepatitis B virus X protein\u2011induced cell growth promotion in hepatocellular carcinoma. Molecular medicine reports. 2016;13(2):1345\u201352.","journal-title":"Molecular medicine reports"},{"key":"5436_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1407434","volume":"14","author":"W Yan","year":"2024","unstructured":"Yan W, Rao D, Fan F, Liang H, Zhang Z, Dong H. Hepatitis B virus X protein and TGF-\u03b2: partners in the carcinogenic journey of hepatocellular carcinoma. Frontiers in Oncology. 2024;14:1407434.","journal-title":"Frontiers in Oncology"},{"issue":"42","key":"5436_CR139","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/onc.2016.89","volume":"35","author":"J Wu","year":"2016","unstructured":"Wu J, Lu M, Li Y, Shang Y, Wang S, Meng Y, et al. Regulation of a TGF-\u03b21-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. Oncogene. 2016;35(42):5468\u201379.","journal-title":"Oncogene"},{"issue":"10","key":"5436_CR140","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jop.13088","volume":"49","author":"A Min","year":"2020","unstructured":"Min A, Xiong H, Wang W, Hu X, Wang C, Mao T, et al. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and \u03b2\u2010catenin. Journal of Oral Pathology & Medicine. 2020;49(10):1019\u201329.","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"1","key":"5436_CR141","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jhep.2012.08.023","volume":"58","author":"AM Cozzolino","year":"2013","unstructured":"Cozzolino AM, Alonzi T, Santangelo L, Mancone C, Conti B, Steindler C, et al. TGF\u03b2 overrides HNF4\u03b1 tumor suppressing activity through GSK3\u03b2 inactivation: implication for hepatocellular carcinoma gene therapy. J Hepatol. 2013;58(1):65\u201372.","journal-title":"J Hepatol"},{"key":"5436_CR142","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.01.037","volume":"392","author":"A Malfettone","year":"2017","unstructured":"Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, et al. Transforming growth factor-\u03b2-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer letters. 2017;392:39\u201350.","journal-title":"Cancer letters"},{"key":"5436_CR143","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2024.00259","author":"X Jin","year":"2024","unstructured":"Jin X, Dong H, Wang J, Ou G, Lai X, Tian X, et al. HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells. Journal of Clinical and Translational Hepatology. 2024. https:\/\/doi.org\/10.14218\/jcth.2024.00259.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"1","key":"5436_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31406-5","volume":"8","author":"B Anfuso","year":"2018","unstructured":"Anfuso B, El-Khobar KE, Ie SI, Avellini C, Radillo O, Raseni A, et al. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model. Scientific REpORTS. 2018;8(1):13168.","journal-title":"Scientific REpORTS"},{"issue":"3","key":"5436_CR145","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/genes9030137","volume":"9","author":"SKK Mani","year":"2018","unstructured":"Mani SKK, Andrisani O. Hepatitis B virus-associated hepatocellular carcinoma and hepatic cancer stem cells. Genes. 2018;9(3):137.","journal-title":"Genes"},{"issue":"3","key":"5436_CR146","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.celrep.2017.03.059","volume":"19","author":"KS Tummala","year":"2017","unstructured":"Tummala KS, Brandt M, Teijeiro A, Grana O, Schwabe RF, Perna C, et al. Hepatocellular carcinomas originate predominantly from hepatocytes and benign lesions from hepatic progenitor cells. Cell reports. 2017;19(3):584\u2013600.","journal-title":"Cell reports"},{"issue":"4","key":"5436_CR147","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/hep.30622","volume":"70","author":"Z Wei","year":"2019","unstructured":"Wei Z, Jia J, Heng G, Xu H, Shan J, Wang G, et al. Sirtuin-1\/mitochondrial ribosomal protein S5 axis enhances the metabolic flexibility of liver cancer stem cells. Hepatology. 2019;70(4):1197\u2013213.","journal-title":"Hepatology"},{"issue":"13","key":"5436_CR148","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.3390\/ijms23136958","volume":"23","author":"J Fan","year":"2022","unstructured":"Fan J, Tian R, Yang X, Wang H, Shi Y, Fan X, et al. KCNN4 promotes the stemness potentials of liver cancer stem cells by enhancing glucose metabolism. Int J Mol Sci. 2022;23(13):6958.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5436_CR149","doi-asserted-by":"publisher","first-page":"C1423","DOI":"10.1152\/ajpcell.00445.2023","volume":"326","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Chavez JA, D\u2019Aquino KE, Meng R, Nawrocki AR, Pocai A, et al. Kynurenine 3-monooxygenase limits de novo NAD+ synthesis through dietary tryptophan in renal proximal tubule epithelial cell models. Am J Physiology-Cell Physiol. 2024;326(5):C1423\u201336.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"8","key":"5436_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081901","volume":"10","author":"H-Y Lee","year":"2021","unstructured":"Lee H-Y, Nga HT, Tian J, Yi H-S. Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells. 2021;10(8):1901.","journal-title":"Cells"},{"key":"5436_CR151","doi-asserted-by":"crossref","unstructured":"Wei Z, Xia J, Liu L, Qian C. SIRT1\/MRPS5 axis enhances the metabolic flexibility of liver cancer stem cells. Pancreas. 2020. 49: 152","DOI":"10.1002\/hep.30622"},{"issue":"12","key":"5436_CR152","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.7150\/ijms.43491","volume":"17","author":"Q Wang","year":"2020","unstructured":"Wang Q, Cheng S-t, Chen J. HBx mediated increase of SIRT1 contributes to HBV-related hepatocellular carcinoma tumorigenesis. Int J Med Sci. 2020;17(12):1783.","journal-title":"Int J Med Sci"},{"key":"5436_CR153","doi-asserted-by":"publisher","first-page":"649197","DOI":"10.3389\/fimmu.2021.649197","volume":"12","author":"S Gu","year":"2021","unstructured":"Gu S, Fu X, Ye G, Chen C, Li X, Zhong S, et al. High L-carnitine levels impede viral control in chronic hepatitis B virus infection. Front Immunol. 2021;12:649197.","journal-title":"Front Immunol"},{"key":"5436_CR154","first-page":"227","volume-title":"Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B Patients. Hepatitis B Virus","author":"C Chua","year":"2024","unstructured":"Chua C, Garc\u00eda-L\u00f3pez M, Gehring AJ. Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B Patients. Hepatitis B Virus. Methods and Protocols: Springer; 2024. pp. 227\u201340."},{"issue":"S2","key":"5436_CR155","first-page":"54","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang X, Ren S, Zheng S, Chen X. Immune status of inactive HBsAg antigen carriers with chronic HBV infection. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi=. Chin J Hepatol. 2024;32(S2):54\u201362.","journal-title":"Chin J Hepatol"},{"key":"5436_CR156","doi-asserted-by":"publisher","first-page":"104816","DOI":"10.1016\/j.antiviral.2020.104816","volume":"179","author":"A Kuipery","year":"2020","unstructured":"Kuipery A, Gehring AJ, Isogawa M. Mechanisms of HBV immune evasion. Antiviral Res. 2020;179:104816.","journal-title":"Antiviral Res"},{"issue":"1","key":"5436_CR157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41389-024-00515-4","volume":"13","author":"W Chen","year":"2024","unstructured":"Chen W, Guo L, Xu H, Dai Y, Yao J, Wang L. NAC1 transcriptional activation of LDHA induces hepatitis B virus immune evasion leading to cirrhosis and hepatocellular carcinoma development. Oncogenesis. 2024;13(1):15.","journal-title":"Oncogenesis"},{"issue":"7","key":"5436_CR158","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.ccell.2023.05.013","volume":"41","author":"AB Chaves-Filho","year":"2023","unstructured":"Chaves-Filho AB, Schulze A. Cholesterol atlas of tumor microenvironment provides route to improved CAR-T therapy. Cancer Cell. 2023;41(7):1204\u20136.","journal-title":"Cancer Cell"},{"key":"5436_CR159","doi-asserted-by":"publisher","first-page":"1489770","DOI":"10.3389\/fimmu.2024.1489770","volume":"15","author":"L Dumolard","year":"2025","unstructured":"Dumolard L, Hilleret M-N, Costentin C, Mercey-Ressejac M, Sturm N, Gerster T, et al. Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients. Front Immunol. 2025;15:1489770.","journal-title":"Front Immunol"},{"issue":"2","key":"5436_CR160","doi-asserted-by":"publisher","first-page":"99292","DOI":"10.4254\/wjh.v17.i2.99292","volume":"17","author":"Z-Y Xu","year":"2025","unstructured":"Xu Z-Y, Gao J-S, He Y, Xiao X-Q, Gong G-Z, Zhang M. Hepatitis B virus confers innate immunity evasion through hepatitis B virus-miR-3 down-regulation of cGAS-Sting-IFN signaling. World J Hepatol. 2025;17(2):99292.","journal-title":"World J Hepatol"},{"key":"5436_CR161","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/jgh.12034","volume":"28","author":"Q Han","year":"2013","unstructured":"Han Q, Lan P, Zhang J, Zhang C, Tian Z. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation. J Gastroenterol Hepatol. 2013;28:132\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5436_CR162","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/hep.26668","volume":"59","author":"L Xu","year":"2014","unstructured":"Xu L, Yin W, Sun R, Wei H, Tian Z. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice. Hepatology. 2014;59(2):443\u201352.","journal-title":"Hepatology"},{"issue":"2","key":"5436_CR163","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jvh.12370","volume":"22","author":"TC Tseng","year":"2015","unstructured":"Tseng TC, Kao JH. Treating immune-tolerant hepatitis B. J Viral Hepatitis. 2015;22(2):77\u201384.","journal-title":"J Viral Hepatitis"},{"key":"5436_CR164","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coviro.2021.08.011","volume":"51","author":"NH Shoukry","year":"2021","unstructured":"Shoukry NH, Walker CM. T cell responses during HBV and HCV infections: similar but not quite the same? Curr Opin Virol. 2021;51:80\u20136.","journal-title":"Curr Opin Virol"},{"issue":"5","key":"5436_CR165","first-page":"001978","volume":"105","author":"HBV Allweiss","year":"2024","unstructured":"Allweiss HBV, Cohen L, Dias C, Fumagalli J, Guo V. Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus. J Gen Virol. 2024;105(5):001978.","journal-title":"J Gen Virol"},{"key":"5436_CR166","doi-asserted-by":"publisher","first-page":"661204","DOI":"10.3389\/fimmu.2021.661204","volume":"12","author":"K Sartorius","year":"2021","unstructured":"Sartorius K, An P, Winkler C, Chuturgoon A, Li X, Makarova J, et al. The epigenetic modulation of cancer and immune pathways in hepatitis B virus-associated hepatocellular carcinoma: the influence of HBx and miRNA dysregulation. Front Immunol. 2021;12:661204.","journal-title":"Front Immunol"},{"key":"5436_CR167","doi-asserted-by":"publisher","first-page":"112509","DOI":"10.1016\/j.intimp.2024.112509","volume":"137","author":"A Gholami","year":"2024","unstructured":"Gholami A. Cancer stem cell-derived exosomes in CD8\u2009+\u2009T cell exhaustion. Int Immunopharmacol. 2024;137:112509.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"5436_CR168","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.7150\/ijbs.101025","volume":"21","author":"F Zheng","year":"2025","unstructured":"Zheng F, Zhang S, Chang AE, Moon JJ, Wicha MS, Wang SX, et al. Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy. Int J Biol Sci. 2025;21(4):1819.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5436_CR169","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12672-023-00787-z","volume":"14","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Chakraborty S, Basak U, Pati S, Dutta A, Dutta S, et al. Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGF\u03b2 to evade immune-elimination. Discover Oncol. 2023;14(1):220.","journal-title":"Discover Oncol"},{"issue":"5","key":"5436_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101302","volume":"7","author":"C Yang","year":"2025","unstructured":"Yang C, Li Y, Wang Z, Shan H, Zhang G, Meng X, et al. Identification of a cancer stem cell-like subpopulation that promotes HCC metastasis. JHEP Reports. 2025;7(5):101302.","journal-title":"JHEP Reports"},{"issue":"6","key":"5436_CR171","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/0008-5472.CAN-23-1916","volume":"84","author":"X Zhang","year":"2024","unstructured":"Zhang X, Su T, Wu Y, Cai Y, Wang L, Liang C, et al. N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression. Cancer research. 2024;84(6):827\u201340.","journal-title":"Cancer research"},{"issue":"1","key":"5436_CR172","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","volume":"16","author":"S-y Jing","year":"2024","unstructured":"Jing S-y, Liu D, Feng N, Dong H, Wang H-q, Yan X, et al. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma. Genome Med. 2024;16(1):98.","journal-title":"Genome Med"},{"issue":"1","key":"5436_CR173","doi-asserted-by":"publisher","first-page":"22966","DOI":"10.1038\/srep22966","volume":"6","author":"H-J Dong","year":"2016","unstructured":"Dong H-J, Jang G-B, Lee H-Y, Park S-R, Kim J-Y, Nam J-S, et al. The Wnt\/\u03b2-catenin signaling\/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells. Sci Rep. 2016;6(1):22966.","journal-title":"Sci Rep"},{"key":"5436_CR174","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/941876","author":"R Morrison","year":"2011","unstructured":"Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE, et al. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. Journal of oncology. 2011. https:\/\/doi.org\/10.1155\/2011\/941876.","journal-title":"Journal of oncology"},{"issue":"1","key":"5436_CR175","doi-asserted-by":"publisher","first-page":"e0146696","DOI":"10.1371\/journal.pone.0146696","volume":"11","author":"P Kongkavitoon","year":"2016","unstructured":"Kongkavitoon P, Tangkijvanich P, Hirankarn N, Palaga T. Hepatitis B virus HBx activates Notch signaling via delta-like 4\/Notch1 in hepatocellular carcinoma. PLoS ONE. 2016;11(1):e0146696.","journal-title":"PLoS ONE"},{"issue":"1","key":"5436_CR176","doi-asserted-by":"publisher","first-page":"e53710","DOI":"10.1371\/journal.pone.0053710","volume":"8","author":"R Koyama-Nasu","year":"2013","unstructured":"Koyama-Nasu R, Takahashi R, Yanagida S, Nasu-Nishimura Y, Oyama M, Kozuka-Hata H, et al. The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels. PLoS ONE. 2013;8(1):e53710.","journal-title":"PLoS ONE"},{"issue":"12","key":"5436_CR177","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1002\/jcp.30899","volume":"237","author":"HT Oh","year":"2022","unstructured":"Oh HT, Heo W, Yoo GD, Kim KM, Hwang JH, Hwang ES, et al. CD133-Src\u2010TAZ signaling stimulates ductal fibrosis following DDC diet\u2010induced liver injury. J Cell Physiol. 2022;237(12):4504\u201316.","journal-title":"J Cell Physiol"},{"issue":"3","key":"5436_CR178","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5483\/BMBRep.2015.48.3.047","volume":"48","author":"D Lee","year":"2015","unstructured":"Lee D, Lee JW. Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44. BMB Rep. 2015;48(3):127.","journal-title":"BMB Rep"},{"issue":"1","key":"5436_CR179","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12935-022-02446-9","volume":"22","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang H, Liao Z, Zhang J, Liang H, Wang W, et al. SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma. Cancer Cell Int. 2022;22(1):24.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"5436_CR180","doi-asserted-by":"publisher","first-page":"272","DOI":"10.14740\/wjon1514","volume":"13","author":"MY Zhu","year":"2022","unstructured":"Zhu MY, Gong ZS, Feng HP, Zhang QY, Liu K, Lin B, et al. Vincosamide Has a Function for Inhibiting Malignant Behaviors of Hepatocellular Carcinoma Cells. World J Oncol. 2022;13(5):272.","journal-title":"World J Oncol"},{"issue":"9","key":"5436_CR181","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1158\/0008-5472.CAN-18-3015","volume":"79","author":"A Takai","year":"2019","unstructured":"Takai A, Dang H, Oishi N, Khatib S, Martin SP, Dominguez DA, et al. Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma. Cancer Res. 2019;79(9):2379\u201391.","journal-title":"Cancer Res"},{"issue":"8","key":"5436_CR182","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/liv.14533","volume":"40","author":"L Rimassa","year":"2020","unstructured":"Rimassa L, W\u00f6rns MA. Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma. Liver Int. 2020;40(8):1800\u201311.","journal-title":"Liver Int"},{"key":"5436_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.212577","volume":"8","author":"D Marino","year":"2019","unstructured":"Marino D, Zichi C, Audisio M, Sperti E, Di Maio M. Second-line treatment options in hepatocellular carcinoma. Drugs Context. 2019;8:1.","journal-title":"Drugs Context"},{"issue":"3","key":"5436_CR184","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00432-022-04057-3","volume":"149","author":"W Wen","year":"2023","unstructured":"Wen W, Zhang Y, Zhang H, Chen Y. Clinical outcomes of PD-1\/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis. J Cancer Res Clin Oncol. 2023;149(3):969\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5436_CR185","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10142-024-01286-2","volume":"24","author":"W Wu","year":"2024","unstructured":"Wu W, Li Y, Wu X, Liang J, You W, He X, et al. RETRACTED ARTICLE: Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma. Funct Integr Genom. 2024;24(1):5.","journal-title":"Funct Integr Genom"},{"issue":"11","key":"5436_CR186","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/eji.200324244","volume":"33","author":"S Tumenjargal","year":"2003","unstructured":"Tumenjargal S, Gellrich S, Linnemann T, Muche JM, Lukowsky A, Audring H, et al. Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor\u2010associated T cell epitope. Eur J Immunol. 2003;33(11):3175\u201385.","journal-title":"Eur J Immunol"},{"issue":"57","key":"5436_CR187","doi-asserted-by":"publisher","first-page":"96649","DOI":"10.18632\/oncotarget.20029","volume":"8","author":"D Feng","year":"2017","unstructured":"Feng D, Hui X, Shi-Chun L, Yan-Hua B, Li C, Xiao-Hui L, et al. Initial experience of anti-PD1 therapy with nivolumab in advanced hepatocellular carcinoma. Oncotarget. 2017;8(57):96649.","journal-title":"Oncotarget"},{"key":"5436_CR188","doi-asserted-by":"publisher","first-page":"712351","DOI":"10.3389\/fimmu.2021.712351","volume":"12","author":"G Liu","year":"2021","unstructured":"Liu G, Zhou W, Li X, Guo L, He T, Zhao J, et al. Case report: complete response of primary massive hepatocellular carcinoma to anti-programmed death ligand-1 antibody following progression on anti-programmed death-1 antibody. Front Immunol. 2021;12:712351.","journal-title":"Front Immunol"},{"issue":"2","key":"5436_CR189","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41419-024-06542-8","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Zhou Q, Xie DF, Xu Q, Yang T, Wang W. LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell Death Dis. 2024;15(2):165.","journal-title":"Cell Death Dis"},{"issue":"5","key":"5436_CR190","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3892\/or.2017.5523","volume":"37","author":"F Zhong","year":"2017","unstructured":"Zhong F, Cheng X, Sun S, Zhou J. Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells. Oncol Rep. 2017;37(5):3061\u20137.","journal-title":"Oncol Rep"},{"issue":"1","key":"5436_CR191","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1038\/s41598-023-42948-8","volume":"13","author":"R Wu","year":"2023","unstructured":"Wu R, Liu W, Yang Q, Zhang J, Hou P, Xiong J, et al. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression. Sci Rep. 2023;13(1):16998.","journal-title":"Sci Rep"},{"issue":"2","key":"5436_CR192","doi-asserted-by":"publisher","first-page":"e001037","DOI":"10.1136\/jitc-2020-001037","volume":"8","author":"R Wu","year":"2020","unstructured":"Wu R, Wang C, Li Z, Xiao J, Li C, Wang X, et al. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA. J Immunother Cancer. 2020;8(2):e001037.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5436_CR193","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-023-02609-0","volume":"42","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xu Q, Deng F, Zheng Z, Luo J, Wang P, et al. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway. J Experimental Clin Cancer Res. 2023;42(1):38.","journal-title":"J Experimental Clin Cancer Res"},{"key":"5436_CR194","doi-asserted-by":"publisher","first-page":"1534723","DOI":"10.3389\/fimmu.2024.1534723","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Tu T. Integrating single cell analysis and machine learning methods reveals stem cell-related gene S100A10 as an important target for prediction of liver cancer diagnosis and immunotherapy. Front Immunol. 2025;15:1534723.","journal-title":"Front Immunol"},{"key":"5436_CR195","doi-asserted-by":"publisher","first-page":"1519324","DOI":"10.3389\/fimmu.2024.1519324","volume":"15","author":"J Shao","year":"2024","unstructured":"Shao J, Zhao T, Liu J, Kang P. Targeting liver cancer stem cells: the prognostic significance of MRPL17 in immunotherapy response. Front Immunol. 2024;15:1519324.","journal-title":"Front Immunol"},{"key":"5436_CR196","doi-asserted-by":"publisher","first-page":"1295693","DOI":"10.3389\/fimmu.2024.1295693","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Guo Y, Yang Y, Ge X. Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation. Front Immunol. 2024;15:1295693.","journal-title":"Front Immunol"},{"key":"5436_CR197","doi-asserted-by":"publisher","DOI":"10.1615\/critreveukaryotgeneexpr.2025056929","author":"Z Lai","year":"2025","unstructured":"Lai Z, Li C. TRIP13 is a potential prognostic marker and therapeutic target for endometrial cancer. Crit Rev Eukaryot Gene Expr. 2025. https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025056929.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"5436_CR198","first-page":"1","volume":"16","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Niu C, Cui J. Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development? J translational Med. 2018;16:1\u201313.","journal-title":"J translational Med"},{"issue":"10","key":"5436_CR199","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1172\/JCI99317","volume":"128","author":"J Hsu","year":"2018","unstructured":"Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault M-C, Trevino TN, et al. Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade. J Clin Investig. 2018;128(10):4654\u201368.","journal-title":"J Clin Investig"},{"issue":"1","key":"5436_CR200","doi-asserted-by":"publisher","first-page":"e000450","DOI":"10.1136\/jitc-2019-000450","volume":"8","author":"KP Fabian","year":"2020","unstructured":"Fabian KP, Padget MR, Donahue RN, Solocinski K, Robbins Y, Allen CT, et al. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations. J Immunother Cancer. 2020;8(1):e000450.","journal-title":"J Immunother Cancer"},{"key":"5436_CR201","doi-asserted-by":"publisher","first-page":"679117","DOI":"10.3389\/fimmu.2021.679117","volume":"12","author":"KA Shaver","year":"2021","unstructured":"Shaver KA, Croom-Perez TJ, Copik AJ. Natural killer cells: the linchpin for successful cancer immunotherapy. Front Immunol. 2021;12:679117.","journal-title":"Front Immunol"},{"issue":"1","key":"5436_CR202","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40164-025-00642-7","volume":"14","author":"B Hao","year":"2025","unstructured":"Hao B, Liu Y, Wang B, Wu H, Chen Y, Zhang L. Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma. Experimental Hematol Oncol. 2025;14(1):44.","journal-title":"Experimental Hematol Oncol"},{"key":"5436_CR203","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian Z. HBV-induced immune imbalance in the development of HCC. Front Immunol. 2019;10:2048.","journal-title":"Front Immunol"},{"issue":"7","key":"5436_CR204","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.7150\/thno.54648","volume":"11","author":"X Dai","year":"2021","unstructured":"Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q, et al. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 2021;11(7):3489\u2013501.","journal-title":"Theranostics"},{"issue":"9","key":"5436_CR205","doi-asserted-by":"publisher","first-page":"e1383","DOI":"10.1016\/S2214-109X(23)00263-2","volume":"11","author":"G Ndow","year":"2023","unstructured":"Ndow G, Vo-Quang E, Shimakawa Y, Ceesay A, Tamba S, Njai HF, et al. Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study. Lancet Glob Health. 2023;11(9):e1383\u201392.","journal-title":"Lancet Glob Health"},{"key":"5436_CR206","doi-asserted-by":"publisher","first-page":"1065644","DOI":"10.3389\/fgene.2022.1065644","volume":"13","author":"K Ma","year":"2022","unstructured":"Ma K, Wu H, Ji L. Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma. Front Genet. 2022;13:1065644.","journal-title":"Front Genet"},{"issue":"1","key":"5436_CR207","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12885-024-12031-0","volume":"24","author":"Y Liang","year":"2024","unstructured":"Liang Y, Zhong D, Zhang Z, Su Y, Yan S, Lai C, et al. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma. BMC Cancer. 2024;24(1):291.","journal-title":"BMC Cancer"},{"issue":"2","key":"5436_CR208","doi-asserted-by":"publisher","first-page":"e001748","DOI":"10.1136\/jitc-2020-001748","volume":"8","author":"Q Liu","year":"2020","unstructured":"Liu Q, Tian Y, Li Y, Zhang W, Cai W, Liu Y, et al. In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma. J Immunother Cancer. 2020;8(2):e001748.","journal-title":"J Immunother Cancer"},{"key":"5436_CR209","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s12072-021-10250-2","volume":"15","author":"F Meng","year":"2021","unstructured":"Meng F, Zhao J, Tan AT, Hu W, Wang S-Y, Jin J, et al. Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial. Hep Intl. 2021;15:1402\u201312.","journal-title":"Hep Intl"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05436-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:03:19Z","timestamp":1790258599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05436-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":209,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5436"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05436-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a review and does not involve human participants or animal studies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1366"}}